|
⚲
|
| Keyboard |
| Hite Christopher
✚
|
|
|---|---|
| CIK # | 0001814238 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001814238] | |
| 4 | [0001814238] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Royalty Pharma PLC | |
| Hite Christopher | |
| Kailera Therapeutics Inc | |
| Vera Therapeutics Inc | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vera Therapeutics Inc VERA
Stock Option (right to buy) · derivative
|
2026-03-05 | Grant | 24,937 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2026-02-11 | Grant | 26,626 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-11-05 | Grant | 6,168 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-08-06 | Grant | 3,696 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class E Ordinary Shares · derivative
|
2025-05-16 | Grant | 1,238,789 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-05-08 | Grant | 48,646 | $0.00 | |
|
Royalty Pharma PLC RPRX
LP interests in RPI US Partners 2019, LP · derivative
|
2025-02-14 | Conversion | 30,000 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-02-14 | Conversion | 300,000 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2024-05-13 | Conversion | 300,000 | $0.00 | |
|
Royalty Pharma PLC RPRX
LP interests in RPI US Partners 2019, LP · derivative
|
2024-05-13 | Conversion | 30,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 1,848 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 10,267 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-11-19 | Tender | 930 | ||
|
Royalty Pharma PLC RPRX
LP interests in RPI US Partners 2019, LP · derivative
|
2021-03-23 | Sell | 31,959 | $469.86 | 15,016,256 |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-01-29 | Grant | 1,848 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-01-29 | Grant | 930 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2020-06-18 | Buy | 70,000 | $28.00 | 1,960,000 |
|
Royalty Pharma PLC RPRX
ICAI Interests · derivative
|
2020-06-15 | Grant | 116,100 | $0.00 | |
|
Royalty Pharma PLC RPRX
LP interests in RPI US Partners 2019, LP · derivative
|
2020-06-15 | Grant | 62,500 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2020-06-04 | Grant | 10,267 | $0.00 |